Advances in nanomedicine for the treatment of infectious diseases caused by viruses

Viruses have a worldwide impact on healthcare and social and economic growth because they are the largest cause of mortality due to infectious diseases. Furthermore, the long-term conventional drug use comes with substantial risks to public health, such as the rapid evolution of drug resistance and the emergence of secondary side effects. Therefore, it is necessary to develop new methods for the treatment of virus-related diseases. In this case, the use of nanomaterial-based nanomedicines possesses tremendous advantages over the traditional treatment approach. Nanomaterial-based drug delivery systems have unique features that make them promising candidates in the pursuit of therapeutic benefits. In this review, we present the various biocompatible nanomaterials that show promise as nanomedicines for anti-viral therapy. Also, we include how current developments in nanomedicine are being used to treat and prevent the most common viral illnesses such as the flu, HIV, SARS-CoV-2, monkeypox, and human papillomaviruses.

Automated summary

Viruses have a huge impact on healthcare and socio-economic growth as they are the leading cause of death from infectious diseases. Traditional drug use poses risks to public health, such as drug resistance and side effects. Therefore, developing new methods for virus-related disease treatment is necessary. Nanomaterial-based nanomedicines offer advantages over traditional treatments and show promise in anti-viral therapy. This review discusses biocompatible nanomaterials and their potential use in treating and preventing common viral illnesses.